By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tobira Therapeutics Inc. 

701 Gateway Boulevard
Suite 300
South San Francisco  California  94080  U.S.A.
Phone: 650-741-6625 Fax: n/a


Company News
Allergan (AGN) Successfully Completes Tobira (TBRA) Acquisition 11/1/2016 6:53:41 AM
Tobira (TBRA) Announces Late-Breaking Oral Presentation Of CENTAUR Phase IIb Trial Results At The American Academy For The Study Of Liver Diseases Annual Meeting 10/20/2016 10:10:59 AM
Allergan (AGN) And Tobira (TBRA) Announce Early Termination Of Hart-Scott-Rodino Waiting Period For Allergan's Proposed Acquisition Of Tobira 10/19/2016 8:17:31 AM
Turns Out Gilead (GILD) May Have Wanted Tobira (TBRA) Too 10/19/2016 6:58:33 AM
A Look at Allergan (AGN)'s Courtship of Bay Area's Tobira (TBRA) 10/4/2016 6:54:19 AM
Tobira (TBRA) Announces Presentations Related To Cenicriviroc’s Development Program In NASH At The American Association for Study of Liver Diseases Annual Meeting 10/3/2016 11:18:28 AM
Continuing Its String of Deals, Allergan (AGN) Buys Bay Area’s Tobira (TBRA) for $1.695 Billion 9/20/2016 6:13:48 AM
Tobira (TBRA) Announces Initiation Of Phase I Combination Study of Cenicriviroc And Evogliptin 9/12/2016 12:25:44 PM
Tobira (TBRA) Announces Appointment Of Dr. Laurent Fischer As Industry Co-Chair Of The Liver Forum Steering Committee 9/7/2016 1:11:09 PM
Tobira (TBRA) To Participate In Two Conferences In September 9/2/2016 10:21:24 AM